Under pressure: K3 to put loss-making UK Microsoft Dynamics reseller biz into administration

AIM-listed biz says THAT virus meant it has little choice, will seek a buyer

Updated AIM-listed software and managed services outfit K3 is to put its loss-making Microsoft Dynamics reseller division into the hands of administrators amid commercial unpredictability caused by COVID-19.

The news was delivered to investors this morning, along with confirmation that the mid-range ERP house had got a £6m loan from Barclays and two shareholders and a reiteration that it was delaying publishing results for the year to 30 November.

The cash funding is going to be used to "strengthen the group's liquidity position during this period of unprecedented disruption caused by the Coronavirus pandemic," K3 said.

In addition to Barclays, Kestrel Partners LLP and non-exec director and stock owner Johan Claesson also contributed to the funding. Barclays will extend its existing loans facilities by £3m to £13m in total and the two shareholders will provide an unsecured loan of £3m.

These are tough times for businesses, with Britain in lockdown as the government tries to contain the spread of the novel coronavirus. It is against this backdrop that K3 decided that it will be "filing a Notice of Intention for administration" for K3 Business Technologies Ltd.

K3 said the reseller wing, which sells Microsoft ERP and CRM wares, turned over £21m in its fiscal '19, accounts for which have been postponed as mentioned above. In that year it generated an operating loss of £3m.

The parent firm added: "Given the current uncertainties created by the coronavirus crisis, this UK subsidiary is expected to generate further significant negative EBITDA (earning before income tax, depreciation and amortisation) and cash outflows in the year to 30 November”.

This may not be the end for the reseller, with K3 saying it "will seek interest in the sale of the business and/or its assets". The decision to get rid of the UK arm has "no effect" on the group's Microsoft Dynamics biz outside UK, the company added.

James Preece, analyst at Megabuyte, said it was "surprising" to see the Dynamics reseller operation being offloaded by K3 "given the strength in other Microsoft players" in the UK.

"Offloading the cash burning business will allow management to focus on accelerating its transition toward its own IP," he added.

K3 sells DataSwitch, a system integration and data manipulation tool; a cloud-based "out of the box" IT retail system; an HR and payroll system; and data warehouse solutions, in addition to a range of products and services based around Microsoft Dynamics.

Customers are based in construction, retail, supply chain, distribution and manufacturing, with names including Cadburys, Typhoo, Levi's and T Mobile.

Over at TechMarketView, researcher Duncan Aitchison pointed to the warning of lower profits and rising debts emitted by K3 last year, the difficulties many have in providing forecast in the current environment and cited talk of delayed contracts or deferrals as reasons why the business may be finding itself on sticky ground.

"Things are unlikely to get appreciably easier soon," he said.

Updated on 14 May at 16.00GMT add:

Microsoft Gold Partner Pythagoras has confirmed it bought the "Dynamics 365 Customer Engagement assets of K3" for an undisclosed sum. ®

Similar topics

Broader topics

Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022